Biofil Chemicals & Pharmaceuticals Ltd. - Research Center
524396 BIOFILCHEM Group (B) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
16.27 |
16.27 |
16.27 |
16.27 |
16.27 |
Share application money
Preference share capital
Reserves & surplus
1.03 |
0.56 |
-0.14 |
-1.39 |
-2.62 |
Secured loans
Unsecured loans
Total
17.83 |
17.30 |
16.56 |
16.08 |
15.29 |
Gross block
11.63 |
11.62 |
11.55 |
11.45 |
11.24 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
9.00 |
9.42 |
9.78 |
10.09 |
10.29 |
Capital work-in-progress
Investments
Current assets, loans & advances
22.41 |
9.31 |
23.46 |
32.27 |
13.92 |
Less : current liabilities & provisions
13.58 |
1.43 |
16.68 |
26.29 |
8.93 |
Total net current assets
Miscellaneous expenses not written
Total
17.83 |
17.30 |
16.56 |
16.08 |
15.29 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
162.74 |
162.74 |
162.74 |
162.74 |
162.74 |